Prix Q/C Technologies Inc (QCLS)

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2008-07-24. The Company, through a licensing agreement with LightSolver, holds rights to the use of quantum-inspired laser-based processing units (LPUs) that solve compute-intensive combinatorial and physical problems at the speed of light. The firm bridges a disruptive computing paradigm for high-speed photonic computing with cryptocurrency infrastructure development at scale, enabling performance and sustainability for blockchain applications. Lightsolver’s architecture is designed to improve security for blockchain operations for the cryptocurrency industry.